AIMS: Computer-assisted signal generation is an important issue for the prevention of adverse drug reactions (ADRs). However, due to poor standardization of patients' medical data and a lack of computable medical drug knowledge the specificity of computerized decision support systems for early ADR detection is too low and thus those systems are not yet implemented in daily clinical practice. We report on a method to formalize knowledge about ADRs based on the Summary of Product Characteristics (SmPCs) and linking them with structured patient data to generate safety signals automatically and with high sensitivity and specificity. METHODS: A computable ADR knowledge base (ADR-KB) that inherently contains standardized concepts for ADRs (WHO-ART), drugs (ATC) and laboratory test results (LOINC) was built. The system was evaluated in study populations of paediatric and internal medicine inpatients. RESULTS: A total of 262 different ADR concepts related to laboratory findings were linked to 212 LOINC terms. The ADR knowledge base was retrospectively applied to a study population of 970 admissions (474 internal and 496 paediatric patients), who underwent intensive ADR surveillance. The specificity increased from 7% without ADR-KB up to 73% in internal patients and from 19.6% up to 91% in paediatric inpatients, respectively. CONCLUSIONS: This study shows that contextual linkage of patients' medication data with laboratory test results is a useful and reasonable instrument for computer-assisted ADR detection and a valuable step towards a systematic drug safety process. The system enables automated detection of ADRs during clinical practice with a quality close to intensive chart review.
AIMS: Computer-assisted signal generation is an important issue for the prevention of adverse drug reactions (ADRs). However, due to poor standardization of patients' medical data and a lack of computable medical drug knowledge the specificity of computerized decision support systems for early ADR detection is too low and thus those systems are not yet implemented in daily clinical practice. We report on a method to formalize knowledge about ADRs based on the Summary of Product Characteristics (SmPCs) and linking them with structured patient data to generate safety signals automatically and with high sensitivity and specificity. METHODS: A computable ADR knowledge base (ADR-KB) that inherently contains standardized concepts for ADRs (WHO-ART), drugs (ATC) and laboratory test results (LOINC) was built. The system was evaluated in study populations of paediatric and internal medicine inpatients. RESULTS: A total of 262 different ADR concepts related to laboratory findings were linked to 212 LOINC terms. The ADR knowledge base was retrospectively applied to a study population of 970 admissions (474 internal and 496 paediatric patients), who underwent intensive ADR surveillance. The specificity increased from 7% without ADR-KB up to 73% in internal patients and from 19.6% up to 91% in paediatric inpatients, respectively. CONCLUSIONS: This study shows that contextual linkage of patients' medication data with laboratory test results is a useful and reasonable instrument for computer-assisted ADR detection and a valuable step towards a systematic drug safety process. The system enables automated detection of ADRs during clinical practice with a quality close to intensive chart review.
Keywords:
ADR reporting system; adverse drug event; adverse drug reaction; computer-assisted pharmacovigilance; decision support systems; knowledge base
Authors: Pamela L Smithburger; Mitchell S Buckley; Sharon Bejian; Katie Burenheide; Sandra L Kane-Gill Journal: Expert Opin Drug Saf Date: 2011-05-04 Impact factor: 4.250
Authors: Anne G Matlow; Catherine M G Cronin; Virginia Flintoft; Cheri Nijssen-Jordan; Mark Fleming; Barbara Brady-Fryer; Mary-Ann Hiltz; Elaine Orrbine; G Ross Baker Journal: BMJ Qual Saf Date: 2011-01-17 Impact factor: 7.035
Authors: Julie A Eckstrand; Ashraf S Habib; Monica M Horvath; Abbie Williamson; Katherine G Gattis; Heidi Cozart; Jeffrey Ferranti Journal: Patient Saf Surg Date: 2009-08-11
Authors: Suehyun Lee; Jongsoo Han; Rae Woong Park; Grace Juyun Kim; John Hoon Rim; Jooyoung Cho; Kye Hwa Lee; Jisan Lee; Sujeong Kim; Ju Han Kim Journal: Drug Saf Date: 2019-05 Impact factor: 5.606
Authors: Axel Newe; Stefan Wimmer; Antje Neubert; Linda Becker; Hans-Ulrich Prokosch; Matthias W Beckmann; Rainer Fietkau; Christian Forster; Markus Friedrich Neurath; Georg Schett; Thomas Ganslandt Journal: PLoS One Date: 2015-08-24 Impact factor: 3.240
Authors: Vladimir T Ivashkin; Elena A Poluektova; Alexey B Glazunov; Mikhail A Putilovskiy; Oleg I Epstein Journal: BMC Gastroenterol Date: 2019-12-31 Impact factor: 3.067